Botulinum Toxin: World Market Study (2019-2023) Featuring Profiles on Key Players Allergan, Ipsen and Revance - ResearchAndMarkets.com
The "Global Botulinum Toxin Market: Size, Trends and Forecasts (2019-2023 Edition)" report has been added to ResearchAndMarkets.com's offering.
The "Global Botulinum Toxin Market: Size, Trends and Forecasts (2019-2023 Edition)" report has been added to ResearchAndMarkets.com's offering.
The global botulinum toxin market has increased at a significant annual growth rate in 2018 as compared to the preceding year 2017 and projections are made that the market would rise in the next five years i.e. 2019-2023 tremendously.
On the basis of product, type the market is divided into Botox, Xeomin and Dysport. The market can be segmented on the basis of application as therapeutics and cosmetic/aesthetic, of which therapeutics govern the market.
The major growth drivers for the botulinum toxin market are an ageing population, escalating numbers of surgeons, upsurge in facial aesthetics procedures, the rising alternative of non-surgical procedures, increasing healthcare spending in emerging markets. Despite the market is governed by various growth drivers, there are certain challenges faced by the market such as potential health risk associated with botulinum toxin and botulinum toxins as bioterror threat.
FDA approval to Botulinum Toxin for new indications, rise in medical tourism, reduced safety concerns and simple and instant characteristic and scope of botulinum toxin in the treatment of Necrotizing Fasciitis are some of the latest trends existing in the market.
The competition in the global botulinum toxin market is stiff and dominated by big players like Allergan. Further, key players of the botulinum toxin market Ipsen and Revance are also profiled with their financial information and respective business strategies.
Key Topics Covered
1. Executive Summary
2. Introduction
2.1 Botulinum Toxin: An Overview
2.2 Botulinum Toxin: Indications Overview
2.3 Botulinum Toxin: Products Overview
3. Global Market Analysis
3.1 Global Botulinum Toxin Market: An Analysis
3.1.1 Global Botulinum Toxin Market by Value
3.2 Global Botulinum Toxin Market: Application Analysis
3.2.1 Global Botulinum Toxin Market by Application
3.2.2 Global Therapeutic Botulinum Toxin Market by Value
3.2.3 Global Cosmetic/Aesthetic Botulinum Toxin Market by Value
3.3 Global Botulinum Toxin Market: Products Analysis
3.3.1 Global Botulinum Toxin Market by Products
3.4 Global Botox Market: An Analysis
3.4.1 Global Botox Market by Value
3.4.2 Global Botox Market by Application
3.5 Global Dysport Market: An Analysis
3.5.1 Global Dysport Market by Value
3.6 Global Xeomin Market: An Analysis
3.6.1 Global Xeomin Market by Value
3.7 Global Botulinum Toxin Market: Regional Analysis
3.7.1 Global Botulinum Toxin Market by Region
4. Regional Market Analysis
4.1 The US Botulinum Toxin Market: An Analysis
4.1.1 The US Botulinum Toxin Market by Value
4.1.2 The US Botulinum Toxin Market by Application
4.2 Europe Botulinum Toxin Market: An Analysis
4.2.1 Europe Botulinum Toxin Market by Value
4.2.2 Europe Botulinum Toxin Market by Application
4.3 Japan Botulinum Toxin Market: An Analysis
4.3.1 Japan Botulinum Toxin Market by Value
4.3.2 Japan Botulinum Toxin Market by Application
4.4 Asia (Excluding Japan) Botulinum Toxin Market: An Analysis
4.4.1 Asia (Excluding Japan) Botulinum Toxin Market by Value
4.4.2 Korea Botulinum Toxin Market by Value
4.4.3 China Botulinum Toxin Market by Value
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Ageing Population
5.1.2 Escalating Number of Plastic Surgeons
5.1.3 Upsurge in Facial Aesthetics Procedures
5.1.4 Rising Alternative of Non-Surgical Procedures
5.1.5 Increasing Healthcare Spending in Emerging Markets
5.2 Challenges
5.2.1 Potential Health Risk Associated with Botulinum Toxin
5.2.2 Botulinum Toxins As Bio-terror Threat
5.3 Market Trends
5.3.1 FDA approval to Botulinum Toxin for new indications
5.3.2 Rise In Medical Tourism
5.3.3 Reduced Safety Concerns and Simple & Instant Characteristic
5.3.4 Scope of Botulinum Toxin in Treatment of Necrotizing Fasciitis
6. Competitive Landscape
6.1 Global Botulinum Toxin Market by Players
6.1.1 Global Botulinum Toxin Market Share by Players
6.1.2 Global Botulinum Toxin Market Key Development Schedule for Players
6.2 The US Botulinum Toxin Market Players: An Analysis
6.2.1 The US Botulinum Toxin Market Share by Players
6.3 Europe Botulinum Toxin Market Players: An Analysis
6.3.1 Europe Botulinum Toxin Market Share by Players
7. Company Profiles
7.1 Allergan PLC
7.2 Ipsen
7.3 Revance Therapeutics Inc.
For more information about this report visit https://www.researchandmarkets.com/r/acddup
View source version on businesswire.com: https://www.businesswire.com/news/home/20191203005502/en/